WHO ICTRP trial
A 24-month, phase IIIb, open-label, single arm, multicenter study assessing the…
NL-OMON37905 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON37905 |
|---|---|
| Public title | A 24-month, phase IIIb, open-label, single arm, multicenter study assessing the efficacy and safety of an individualized, stabilization criteria-driven pro re rata (PRN) dosing regimen with 0.5-mg ranibizumab intravitreal injections applied as monotherapy in patients with visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO). |
| Scientific title | A 24-month, phase IIIb, open-label, single arm, multicenter study assessing the efficacy and safety of an individualized, stabilization criteria-driven pro re rata (PRN) dosing regimen with 0.5-mg ranibizumab intravitreal injections applied as monotherapy in patients with visual impairment due to… |
| Primary sponsor | Novartis |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | Australia;Austria;Belgium;Canada;Czechia;Denmark;France;Greece;Hungary;Ireland;Italy;Netherlands ;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom |
| Conditions | visual impairment;10047060;visual impairment |
| Interventions | The investigational treatment is 0.5 mg ranibizumab administered PRN by intravitreal injections. ;central retinal vein occlusion (CRVO);macular edema;visual impairment |
| Registration date | Sep 19, 2012 |
| Target size | 25 |
| Secondary IDs | 2011-002350-31;NCT01535261;NL38012.058.11 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: